Cardiac Adrenoceptors: Physiological and Pathophysiological Relevance
Tài liệu tham khảo
1 Bylund DB, Bond RA, Clarke DE, Eikenburg DC, Hieble JP, Langer SZ, et al. Adrenoceptors. The IUPHAR compendium of receptor characterization and classification. London: IUPHAR Media; 1998, p. 58–74.
BRODDE O-E, 1999, 51, 651
3 Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G-protein. Circulation. 1999;100:2210–2212.
1995, 47, 322
9 Xiao R-P, Cheng H, Zhou YY, Kuschel M, Lakatta EG. Recent advances in cardiac β<sub>2</sub>-adrenergic signal transduction. Circ Res. 1999;85:1092–1100.
16 Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, et al. β<sub>2</sub>-Adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G<sub>s</sub> and G<sub>i</sub>. Circ Res. 2000;87:705–709.
18 Kaumann A, Bartel S, Molenaar P, Sanders L, Burrell K, Vetter D, et al. Activation of β<sub>2</sub>-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation. 1999;99:65–72.
19 Molenaar P, Bartel S, Cochrane A, Vetter D, Jalali H, Pohlner P, et al. Both β<sub>2</sub>- and β<sub>1</sub>-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of β<sub>2</sub>-adrenergic receptors to G<sub>s</sub>-protein. Circulation. 2000;102:1814–1821.
1988, 247, 1039
1993, 45, 147
66 Li Z, Laugwitz K-L, Pinkernell K, Pragst I, Baumgartner C, Hoffmann E, et al. Effects of two Gβγ-binding proteins – N-terminally truncated phosducin and β-adrenergic receptor kinase C terminus (βARKct) – in heart failure. Gene Therapy. 2003;10:1354–1361.
69 Leineweber K, Büscher R, Bruck H, Brodde O-E. β-Adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:1–22.
103 Brodde O-E, Leineweber K. β<sub>2</sub>-Adrenoceptor gene polymorphisms. Pharmacogenet Genomics. 2005;15:267–275.
107 Brodde O-E, Büscher R, Tellkamp R, Radke J, Dhein S, Insel PA. Blunted cardiac responses to receptor activation in subjects with Thr164Ile β<sub>2</sub>-adrenoceptors. Circulation. 2001;103:1048–1050.
114 Cockroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, et al. β<sub>2</sub>-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension. 2000;36:371–375.
121 Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, et al. Polymorphisms of the β<sub>2</sub>-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res. 2000;86:834–840.